Formulation and optimization of zidovudine niosomes

AAPS PharmSciTech

Volumn 11, Issue 3, 2010, Pages 1119-1127

  Ruckmani, Kandasamy ^a   Sankar, Veintramuthu ^b  

^a ANNA UNIVERSITY   (India)

^b PSG COLLEGE OF PHARMACY   (India)

Author keywords

AZT; entrapment efficacy; niosomes; process related variables; zidovudine

Indexed keywords

CHOLESTEROL; DICETYL PHOSPHATE; NIOSOME; ZIDOVUDINE;

ARTICLE; CENTRIFUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; EVAPORATION; HYDRATION; KINETICS; OSMOTIC STRESS; PRIORITY JOURNAL; ROTATION; SUSTAINED RELEASE PREPARATION; ULTRASOUND; VISCOSITY;

ANTI-HIV AGENTS; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG COMPOUNDING; KINETICS; LIPOSOMES; ZIDOVUDINE;

EID: 78649905371     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9480-2     Document Type: Article

References (31)

1. Florence AT, Bailie AJ. Non-ionic surfactant vesicles: alternatives to liposomes in drug delivery? In: Prescot LF, Nimmo WS, editors. Novel drug delivery and its therapeutic applications. Chichester: Wiley, Inc; 1989. p. 281-96.
2. Florence AT, Cable C, Cassidy J, Kaze SB. Non-ionic surfactant vesicles as carriers of doxorubicin. In: Gregoriadis G, editor. Targeting of drugs. New York: Plenum, Inc; 1990. p. 117-26.
3. KS Chandraprakash N Uduppa P Umadevi GK Pillai 1993 Effect of niosome encapsulation of methotrexate, macrophage activation, and tissue distribution of methotrexate and tumor size Drug Deliv 1 333 337 10.3109/10717549309022767
4. G Parthasarathy N Uduppa P Umadevi GK Pillai 1994 Niosome encapsulation of vincristine sulphate: improved anticancer activity with reduced toxicity in mice J Drug Target 2 173 182 10.3109/10611869409015907
5. KD Kieburtz M Lambert Seidlin DR JS 1992 Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine J Acquir Immune Defic Syndr 41 407
6. D Gopinath SR Parakh R Devraj SS Apte RB Rao D Rambhau 2002 Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol J Colloid Interface Sci 251 360 365 10.1006/jcis.2002.8399 (Pubitemid 34775403)
7. D Gopinath D Ravia DR Rao SS Apte D Renuka D Rambhau 2004 Ascorbyl palmitate vesicles (aspasomes): formation, characterization and applications Int J Pharm 271 95 113 1:CAS:528:DC%2BD2cXhtVektL0%3D 10.1016/j.ijpharm.2003.10.032 15129977 (Pubitemid 38210088)
8. AC Julie W Amanda M Samir 2008 Role of particle size in phagocytosis of polymeric microspheres Pharm Res 25 1815 1821 10.1007/s11095-008-9562-y
9. K Arun B Roger B Guru 2000 Effect of liposome composition and cholesterol on the cellular uptake of stavudine by human monocyte/macrophages Cell Mol Biol Lett 5 483 493
10. SC Fang Y Pei 2006 Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosome surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity J Pharm Sci 95 1873 1887 10.1002/jps.20491 16795003 (Pubitemid 44433020)
11. S Alisagar A Misra 2002 Studies in topical application of niosomally entrapped nimesulide J Pharm Pharmaceut Sci 5 220 225
12. S Jain B Umamaheswari D Bhadra NK Jain 2004 Ethosomes: a novel carrier for enhanced transdermal delivery of an anti-HIV agent Indian J Pharm Sci 66 1 72 1:CAS:528:DC%2BD2cXitVGjtLs%3D
13. R Agarwal OP Katare SP Vyas 2001 Preparation and in vitro evaluation of liposomal/niosomal delivery systems for anti-psoriatic drug dithranol Int J Pharm 228 43 52 1:CAS:528:DC%2BD3MXntVWku7c%3D 10.1016/S0378-5173(01)00810-9 11576767 (Pubitemid 32905364)
14. Y Perrie JE Barralet S McNeil A Vangala 2004 Surfactant vesicle-mediated delivery of DNA vaccines via the subcutaneous route Int J Pharm 284 31 41 1:CAS:528:DC%2BD2cXnvVCjtb0%3D 10.1016/j.ijpharm.2004.07.012 15454294 (Pubitemid 39349136)
15. IA Alsarra AA Bosela SM Ahmed GM Mahrous 2005 Proniosomes as a drug carrier for transdermal delivery of ketorolac Eur J Biopharm 59 485 490 1:CAS:528:DC%2BD2MXit1Chsrc%3D 10.1016/j.ejpb.2004.09.006 (Pubitemid 40342523)
16. SP Vyas N Venkatesan 1999 Poly (phthaloyl-l-lysine)-coated multilamellar vesicles for controlled drug delivery: in vitro and in vivo performance evaluation Pharm Acta Helv 74 51 58 1:CAS:528:DC%2BD3cXltVGmtw%3D%3D 10.1016/S0031-6865(99)00016-3 10748624 (Pubitemid 30035403)
17. P Arunothayanun IF Uchegbu DQM Craig JA Turton AT Florence 1999 In vitro/in vivo characterisation of polyhedral niosomes Int J Pharm 183 57 61 1:CAS:528:DyaK1MXjsFKlsLk%3D 10.1016/S0378-5173(99)00044-7 10361155 (Pubitemid 29248829)
18. L Zhang M Yang Q Wang Y Li R Guo X Jiang, et al. 2007 10-Hydroxycamptothecin-loaded nanoparticles: preparation and antitumor activity in mice J Control Rel 119 153 162 1:CAS:528:DC%2BD2sXlsFaju7Y%3D 10.1016/j.jconrel.2007.02.013 (Pubitemid 46754506)
19. M Roser D Fischer T Kiser 1998 Surface-modified biodegradable albumin nano and microspheres. II: Effect of surface charges on in vitro phagocytes and biodistribution in rats Eur J Pharm Biopharm 46 255 263 1:CAS:528: DyaK1MXks1ektA%3D%3D 10.1016/S0939-6411(98)00038-1 9885296 (Pubitemid 29057671)
20. AI Blazek-Welsh DG Rhodes 2001 Maltodextrin-based proniosomes AAPS PharmSci 3 1 8 10.1208/ps030101
21. SG Ahmed DM Nahed M Samar MH Rania 2005 Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide Int J Pharm 306 71 82 10.1016/j.ijpharm.2005.09.023 (Pubitemid 41643141)
22. Y Toshimitsu S Brigitte TF Alexander 1994 Preparation and properties of vesicles (niosomes) of sorbitan monoester (Span 20, 40, 60 and 80) and sorbitan trimester (Span 85) Int J Pharm 105 1 6 10.1016/0378-5173(94)90228-3 (Pubitemid 24087666)
23. JD Gier JG Mandersloot LLM VanDeenen 1968 Reviews on biomembranes Biochim Biophys Acta 150 666 675 10.1016/0005-2736(68)90056-4 5690752
24. Uchegbu IF (1994) Some aspects of the niosomal delivery of doxorubicin. Ph. D. thesis. University of London, England
25. A Raz C Bucanna WE Folger G Poste IJ Fidler 1981 Biochemical, morphological and ultrastructural studies on the uptake of liposomes by murine macrophages Cancer Res 41 487 494 1:CAS:528:DyaL3MXot1SgsA%3D%3D 7448797
26. MJ Hsu RL Juliano 1982 Interaction of liposomes with the reticuloendothelial system. II: nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages Biochim Biophys Acta 720 411 419 1:CAS:528:DyaL38XltVyntrs%3D 10.1016/0167-4889(82)90120-3 6896828
27. A Rogerson J Cummings AT Florence 1987 Adriamycin-loaded niosomes: drug entrapment, stability and release J Microencapsul 4 321 328 1:CAS:528: DyaL1cXhtlOkt7k%3D 10.3109/02652048709021824 3504513
28. E Cohen 1975 The permeability of liposomes to non-electrolytes. I. Activation energies for permeation J Membr Biol 20 205 234 1:CAS:528: DyaE2MXkslequ70%3D 10.1007/BF01870637 1170332
29. M Manconi D Valenti C Sinico F Lai G Loy AM Fadda 2002 Niosomes as carriers for tretinoin. I. Preparation and properties Int J Pharm 234 237 248 1:CAS:528:DC%2BD38XhtFKjsro%3D 10.1016/S0378-5173(01)00971-1 11839454 (Pubitemid 34142628)
30. ND Weiner N Williams G Birch C Ramachandran C Shipman GL Flynn 1989 Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model Antimicrob Agents Chemother 33 1217 1221 1:CAS:528:DyaL1MXltValtr0%3D 2802550
31. MK Das K RamaRao 2007 Microencapsulation of zidovudine by double emulsion solvent diffusion technique using ethyl cellulose Indian J Pharm Sci 69 244 250 1:CAS:528:DC%2BD1MXhtVGqsLvM 10.4103/0250-474X.33151